Meril Loses Bid To Delay UPC Hearing In Feud With Edwards

Meril Life Sciences Pvt. Ltd. lost a bid Wednesday to push back a hearing aimed at determining whether a rival's heart valve patent is invalid, with Europe's patent court finding that...

Already a subscriber? Click here to view full article